Penserra Capital Management LLC Sells 1,548 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Penserra Capital Management LLC trimmed its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 32.4% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 3,232 shares of the medical equipment provider’s stock after selling 1,548 shares during the period. Penserra Capital Management LLC’s holdings in Intuitive Surgical were worth $1,587,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Mirador Capital Partners LP increased its position in shares of Intuitive Surgical by 1.4% during the third quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock valued at $1,732,000 after acquiring an additional 50 shares during the last quarter. Consolidated Planning Corp increased its position in shares of Intuitive Surgical by 17.4% during the 3rd quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock valued at $3,979,000 after purchasing an additional 1,198 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund increased its position in shares of Intuitive Surgical by 617.1% during the 2nd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 89,069 shares of the medical equipment provider’s stock valued at $39,622,000 after purchasing an additional 76,649 shares during the last quarter. Swiss National Bank raised its stake in shares of Intuitive Surgical by 0.3% during the 3rd quarter. Swiss National Bank now owns 1,052,800 shares of the medical equipment provider’s stock worth $517,209,000 after purchasing an additional 3,400 shares during the period. Finally, ABLE Financial Group LLC bought a new position in Intuitive Surgical during the third quarter valued at about $604,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have commented on ISRG. Redburn Atlantic raised shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and lifted their price objective for the stock from $380.00 to $510.00 in a research report on Friday, August 2nd. Stifel Nicolaus upped their price objective on Intuitive Surgical from $475.00 to $525.00 and gave the company a “buy” rating in a research note on Friday, October 18th. Robert W. Baird increased their price objective on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a report on Thursday, October 17th. BTIG Research upped their price target on Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research report on Tuesday. Finally, Leerink Partners increased their price target on Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. One analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have assigned a buy rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $526.06.

Insider Activity at Intuitive Surgical

In other news, EVP Robert Desantis sold 188 shares of the firm’s stock in a transaction on Thursday, August 29th. The shares were sold at an average price of $482.21, for a total transaction of $90,655.48. Following the sale, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,655,048.26. This trade represents a 3.30 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, SVP Mark Brosius sold 2,128 shares of the company’s stock in a transaction on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total transaction of $1,095,920.00. Following the completion of the transaction, the senior vice president now owns 273 shares of the company’s stock, valued at $140,595. This trade represents a 88.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 50,647 shares of company stock valued at $26,170,907 over the last three months. 0.80% of the stock is owned by corporate insiders.

Intuitive Surgical Price Performance

ISRG opened at $542.10 on Wednesday. Intuitive Surgical, Inc. has a one year low of $304.50 and a one year high of $552.00. The firm has a market capitalization of $193.09 billion, a P/E ratio of 87.15, a price-to-earnings-growth ratio of 5.39 and a beta of 1.39. The company has a fifty day moving average price of $506.81 and a 200-day moving average price of $466.29.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping the consensus estimate of $1.24 by $0.32. The business had revenue of $2.04 billion during the quarter, compared to analysts’ expectations of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. On average, analysts expect that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.